Literature DB >> 24333726

Cancer stem cells: A contentious hypothesis now moving forward.

Michael L O'Connor1, Dongxi Xiang1, Sarah Shigdar1, Joanna Macdonald1, Yong Li2, Tao Wang1, Chunwen Pu3, Zhidong Wang3, Liang Qiao4, Wei Duan5.   

Abstract

Cancer stem cells are a progressive concept to account for the cell biological nature of cancer. Despite the controversies regarding the cancer stem cell model, it has the potential to provide a foundation for new innovative treatment targeting the roots of cancer. The last two years have witnessed exceptional progress in cancer stem cell research, in particular on solid tumours, which holds promise for improved treatment outcomes. Here, we review recent advances in cancer stem cell research, discuss challenges in the field and explore future strategies and opportunities in cancer stem cell studies to overcome resistance to chemotherapy.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Aptamers; Cancer stem cells; Chemoresistance; Clonal evolution; Stemness

Mesh：

Year:  2013        PMID： 24333726     DOI： 10.1016/j.canlet.2013.11.012

Source DB:  PubMed          Journal:  Cancer Lett        ISSN： 0304-3835            Impact factor:   8.679


  101 in total

1.  BRM270 Suppresses Cervical Cancer Stem Cell Characteristics and Progression by Inhibiting SOX2.

Authors:  Nisansala Chandimali; Hu-Nan Sun; Yang Ho Park; Taeho Kwon
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 2.  Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities.

Authors:  Ali Hassanzadeh; Heshu Sulaiman Rahman; Alexander Markov; Judi Januadi Endjun; Angelina Olegovna Zekiy; Max Stanley Chartrand; Nasrin Beheshtkhoo; Mohammad Amin Jadidi Kouhbanani; Faroogh Marofi; Marzieh Nikoo; Mostafa Jarahian
Journal:  Stem Cell Res Ther       Date:  2021-05-21       Impact factor: 6.832

Review 3.  Cancer stem cells as a potential therapeutic target in breast cancer.

Authors:  Mingzhi Zhang; Zhaoming Li; Xudong Zhang; Yu Chang
Journal:  Stem Cell Investig       Date:  2014-07-16

Review 4.  Prognostic value of cancer stem cell marker CD133 in ovarian cancer: a meta-analysis.

Authors:  Quan Zhou; Aihua Chen; Huamei Song; Jing Tao; Huaijie Yang; Manzhen Zuo
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 5.  Common stemness regulators of embryonic and cancer stem cells.

Authors:  Christiana Hadjimichael; Konstantina Chanoumidou; Natalia Papadopoulou; Panagiota Arampatzi; Joseph Papamatheakis; Androniki Kretsovali
Journal:  World J Stem Cells       Date:  2015-10-26       Impact factor: 5.326

Review 6.  [Removal of the primary tumor in hematogenous metastatic tumor disease: reasons against].

Authors:  J Huber; C Groeben; M P Wirth
Journal:  Urologe A       Date:  2014-06       Impact factor: 0.639

Review 7.  Therapeutic resistance and cancer recurrence mechanisms: Unfolding the story of tumour coming back.

Authors:  Mohammad Javad Dehghan Esmatabadi; Babak Bakhshinejad; Fatemeh Movahedi Motlagh; Sadegh Babashah; Majid Sadeghizadeh
Journal:  J Biosci       Date:  2016-09       Impact factor: 1.826

8.  Editorial: Special Section on Multiscale Cancer Modeling.

Authors:  Zhihui Wang; Philip K Maini
Journal:  IEEE Trans Biomed Eng       Date:  2017-02-22       Impact factor: 4.538

Review 9.  Differential role of Hedgehog signaling in human pancreatic (patho-) physiology: An up to date review.

Authors:  Eckhard Klieser; Stefan Swierczynski; Christian Mayr; Tarkan Jäger; Johanna Schmidt; Daniel Neureiter; Tobias Kiesslich; Romana Illig
Journal:  World J Gastrointest Pathophysiol       Date:  2016-05-15

10.  Comparison of leucine-rich repeat-containing G protein-coupled receptor 5 expression in different cancer and normal cell lines.

Authors:  Reza Alizadeh-Navaei; Alireza Rafiei; Saeid Abedian-Kenari; Hossein Asgarian-Omran; Reza Valadan; Akbar Hedayatizadeh-Omran
Journal:  Biomed Rep       Date:  2016-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.